» Articles » PMID: 26133461

Functional Imaging Biomarkers: Potential to Guide an Individualised Approach to Radiotherapy

Overview
Specialty Oncology
Date 2015 Jul 3
PMID 26133461
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The identification of robust prognostic and predictive biomarkers would transform the ability to implement an individualised approach to radiotherapy. In this regard, there has been a surge of interest in the use of functional imaging to assess key underlying biological processes within tumours and their response to therapy. Importantly, functional imaging biomarkers hold the potential to evaluate tumour heterogeneity/biology both spatially and temporally. An ever-increasing range of functional imaging techniques is now available primarily involving positron emission tomography and magnetic resonance imaging. Small-scale studies across multiple tumour types have consistently been able to correlate changes in functional imaging parameters during radiotherapy with disease outcomes. Considerable challenges remain before the implementation of functional imaging biomarkers into routine clinical practice, including the inherent temporal variability of biological processes within tumours, reproducibility of imaging, determination of optimal imaging technique/combinations, timing during treatment and design of appropriate validation studies.

Citing Articles

The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature.

Secerov Ermenc A, Segedin B Cancers (Basel). 2023; 15(11).

PMID: 37296929 PMC: 10252061. DOI: 10.3390/cancers15112967.


A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer.

Portner R, Bajaj A, Elumalai T, Huddart R, Murthy V, Nightingale H Clin Transl Radiat Oncol. 2021; 31:1-7.

PMID: 34466667 PMC: 8385113. DOI: 10.1016/j.ctro.2021.08.003.


Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy.

Akram F, Koh P, Wang F, Zhou S, Tan S, Paknezhad M PLoS One. 2020; 15(10):e0240043.

PMID: 33017440 PMC: 7535039. DOI: 10.1371/journal.pone.0240043.


Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.

Cliffe H, Patel C, Prestwich R, Scarsbrook A Br J Radiol. 2016; 90(1071):20160764.

PMID: 28008773 PMC: 5601535. DOI: 10.1259/bjr.20160764.


The feasibility of atlas-based automatic segmentation of MRI for H&N radiotherapy planning.

Wardman K, Prestwich R, Gooding M, Speight R J Appl Clin Med Phys. 2016; 17(4):146-154.

PMID: 27455480 PMC: 5690045. DOI: 10.1120/jacmp.v17i4.6051.